Financial Solutions for Plaintiffs Involved in Xarelto Litigation

Jacky Gale | July 11th, 2018

There are over 20,000 product liability lawsuits pending with regard to the alleged complications caused by Xarelto—a new generation of blood thinner. These plaintiffs have already been waiting a long time for their day in court, and recently, they received news of yet another legal setback. The U.S. District Judge presiding over the multidistrict litigation (MDL) recently heard arguments over whether or not to allow the defendants, Johnson & Johnson and Bayer, to file an immediate appeal. The defendants argue that the claims are pre-empted by federal law.

Prolonged litigation leads to hardship for Xarelto plaintiffs

Some Xarelto plaintiffs have already been waiting for compensation since before 2014. This was when the federal lawsuits were centralized into the MDL in the Eastern District of Louisiana before Judge Eldon Fallon. In the meantime, many of these plaintiffs have been struggling to make ends meet.

Complications allegedly tied to Xarelto can potentially lead to lengthy hospital stays, exorbitant medical bills, the need for ongoing medical care, and missed time at work. Some families going through prolonged litigation are suddenly reduced to just one income source. Even worse, if a patient loses his job or passes away due to health complications, his family may lose their employment-sponsored health insurance, leading to ever-increasing medical bills that won’t get paid.

Financial solutions for Xarelto plaintiffs

Some Xarelto plaintiffs may feel pressure to settle prematurely. When cash is desperately needed right now, it might seem worth it to accept less money than what the case is worth. But there’s an alternative solution: Legal funding. Legal funding is a cash advance made against the promise of a future settlement or jury award. It gives plaintiffs the cash in their pockets that they need now to pay medical bills or legal fees. Plus, pre-settlement funding can pay for anything—from rent and mortgage to groceries and gas, there are no limitations.

People often decide to apply for legal funding when they realize it’s non-recourse, meaning there’s zero risk to them. If the lawsuit doesn’t end favorably with a jury award or settlement, the plaintiffs pay nothing. If the plaintiffs do receive a settlement check or jury award, they will pay back the cash advance, plus a reasonable amount of interest. Legal funding for Xarelto lawsuits is a way to bridge the gap until the litigation finally moves forward.

A trusted source of legal funding for Xarelto plaintiffs

LawStreet Capital understands the importance of trustworthiness in the legal funding industry. We’ve been an industry leader for years, with some of the most competitive rates you’ll find anywhere. LawStreet Capital is committed to complete transparency—you’ll never find a hidden fee in any of our transactions. If you have Xarelto litigation pending, or any other sort of lawsuit, and you need cash in your pocket today, give us a call at 888.562.0363.

And remember, LawStreet Capital offers non-recourse legal funding, which means you won’t pay a dime if you lose your case. There’s absolutely no risk to you, and LawStreet Capital can provide 24-hour approval, with no credit check required. Call today! Or, fill out the quick form on our website to find out if you could have cash in your hand overnight.

Additional resources for Xarelto plaintiffs:

  1. Mayo Clinic, Rivaroxaban (Oral Route), https://www.mayoclinic.org/drugs-supplements/rivaroxaban-oral-route/description/drg-20075013
  2. WebMD, Some Bleeding Risk Seen With Xarelto Vs. Pradaxa, https://www.webmd.com/heart-disease/atrial-fibrillation/news/20161003/some-increased-bleeding-risk-seen-with-blood-thinner-xarelto-vs-pradaxa#1